These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 37377449)

  • 1. Coronary Microvascular Spasm: Clinical Presentation and Diagnosis.
    Godo S; Takahashi J; Shiroto T; Yasuda S; Shimokawa H
    Eur Cardiol; 2023; 18():e07. PubMed ID: 37377449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Mental Stress in Ischaemia with No Obstructive Coronary Artery Disease and Coronary Vasomotor Disorders.
    van der Meer RE; Maas AH
    Eur Cardiol; 2021 Feb; 16():e37. PubMed ID: 34721671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary Microvascular Dysfunction.
    Vancheri F; Longo G; Vancheri S; Henein M
    J Clin Med; 2020 Sep; 9(9):. PubMed ID: 32899944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case report: assessment and management of myocardial infarction and non-obstructive coronary arteries (MINOCA): the role of microvascular coronary vasospasm.
    Marpuri R; Joung S; Gadh A; Dhawan S; Al-Badri A; Pacheco C; Wei J; Merz CNB
    Cardiovasc Diagn Ther; 2019 Aug; 9(4):400-405. PubMed ID: 31555546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiology and Diagnosis of Coronary Functional Abnormalities.
    Takahashi J; Suda A; Nishimiya K; Godo S; Yasuda S; Shimokawa H
    Eur Cardiol; 2021 Feb; 16():e30. PubMed ID: 34603510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical, angiographic and echocardiographic correlates of epicardial and microvascular spasm in patients with myocardial ischaemia and non-obstructive coronary arteries.
    Montone RA; Niccoli G; Russo M; Giaccari M; Del Buono MG; Meucci MC; Gurgoglione F; Vergallo R; D'Amario D; Buffon A; Leone AM; Burzotta F; Aurigemma C; Trani C; Liuzzo G; Lanza GA; Crea F
    Clin Res Cardiol; 2020 Apr; 109(4):435-443. PubMed ID: 31270616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ischemia and no obstructive coronary arteries (INOCA): A narrative review.
    Mehta PK; Huang J; Levit RD; Malas W; Waheed N; Bairey Merz CN
    Atherosclerosis; 2022 Dec; 363():8-21. PubMed ID: 36423427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced Microvascular Blood Volume as a Driver of Coronary Microvascular Disease in Patients With Non-obstructive Coronary Artery Disease: Rationale and Design of the MICORDIS Study.
    Vink CEM; van de Hoef TP; Götte MJW; Eringa EC; Appelman Y
    Front Cardiovasc Med; 2021; 8():730810. PubMed ID: 34660730
    [No Abstract]   [Full Text] [Related]  

  • 9. Presence of Coronary Endothelial Dysfunction, Coronary Vasospasm, and Adenosine-Mediated Vasodilatory Disorders in Patients With Ischemia and Nonobstructive Coronary Arteries.
    Feenstra RGT; Boerhout CKM; Woudstra J; Vink CEM; Wittekoek ME; de Waard GA; Appelman Y; Eringa EC; Marques KMJ; de Winter RJ; Beijk MAM; van de Hoef TP; Piek JJ
    Circ Cardiovasc Interv; 2022 Aug; 15(8):e012017. PubMed ID: 35904014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Relevance of Ischemia with Nonobstructive Coronary Arteries According to Coronary Microvascular Dysfunction.
    Lee SH; Shin D; Lee JM; van de Hoef TP; Hong D; Choi KH; Hwang D; Boerhout CKM; de Waard GA; Jung JH; Mejia-Renteria H; Hoshino M; Echavarria-Pinto M; Meuwissen M; Matsuo H; Madera-Cambero M; Eftekhari A; Effat MA; Murai T; Marques K; Doh JH; Christiansen EH; Banerjee R; Kim HK; Nam CW; Niccoli G; Nakayama M; Tanaka N; Shin ES; Chamuleau SAJ; van Royen N; Knaapen P; Koo BK; Kakuta T; Escaned J; Piek JJ;
    J Am Heart Assoc; 2022 May; 11(9):e025171. PubMed ID: 35475358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ischemia and No Obstructive Coronary Artery Disease: Prevalence and Correlates of Coronary Vasomotion Disorders.
    Ford TJ; Yii E; Sidik N; Good R; Rocchiccioli P; McEntegart M; Watkins S; Eteiba H; Shaukat A; Lindsay M; Robertson K; Hood S; McGeoch R; McDade R; McCartney P; Corcoran D; Collison D; Rush C; Stanley B; McConnachie A; Sattar N; Touyz RM; Oldroyd KG; Berry C
    Circ Cardiovasc Interv; 2019 Dec; 12(12):e008126. PubMed ID: 31833416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. INOCA/ANOCA: Mechanisms and novel treatments.
    Ashokprabhu ND; Quesada O; Alvarez YR; Henry TD
    Am Heart J Plus; 2023 Jun; 30():. PubMed ID: 37377840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of coronary microvascular dysfunction.
    Bairey Merz CN; Pepine CJ; Shimokawa H; Berry C
    Cardiovasc Res; 2020 Mar; 116(4):856-870. PubMed ID: 32087007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contemporary and future invasive coronary vasomotor function testing and treatment in patients with ischaemia with no obstructive coronary arteries.
    Damman P; Elias-Smale SE; Jansen TPJ; Konst RE; Dimitriu-Leen AC; Hartzema M; van Royen N; Maas AHEM
    Eur Heart J Suppl; 2022 Nov; 24(Suppl H):H18-H24. PubMed ID: 36382006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of nonobstructive coronary stenosis on coronary microvascular dysfunction and long-term outcomes in patients with INOCA.
    Mohammed AA; Zhang H; Abdu FA; Liu L; Singh S; Lv X; Shi T; Mareai RM; Mohammed AQ; Yin G; Zhang W; Xu Y; Che W
    Clin Cardiol; 2023 Feb; 46(2):204-213. PubMed ID: 36567512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of combined coronary angiography-derived IMR and myocardial perfusion imaging by CZT SPECT in INOCA.
    Liu L; Dai N; Yin G; Zhang W; Mohammed AQ; Xu S; Lv X; Shi T; Feng C; Mohammed AA; Mareai RM; Xu Y; Yu X; Abdu FA; Yu F; Che W
    J Nucl Cardiol; 2023 Apr; 30(2):684-701. PubMed ID: 35918592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ischemia With Nonobstructive Coronary Artery Disease: Concept, Assessment, and Management.
    Hwang D; Park SH; Koo BK
    JACC Asia; 2023 Apr; 3(2):169-184. PubMed ID: 37181394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ischaemia with no obstructive coronary arteries.
    Konst RE; Meeder JG; Wittekoek ME; Maas AHEM; Appelman Y; Piek JJ; van de Hoef TP; Damman P; Elias-Smale SE
    Neth Heart J; 2020 Aug; 28(Suppl 1):66-72. PubMed ID: 32780334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ischemia and no obstructive coronary arteries in patients with stable ischemic heart disease.
    Mehta PK; Quesada O; Al-Badri A; Fleg JL; Volgman AS; Pepine CJ; Merz CNB; Shaw LJ
    Int J Cardiol; 2022 Feb; 348():1-8. PubMed ID: 34902504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of Diltiazem to Improve Coronary Vasomotor Dysfunction in ANOCA: The EDIT-CMD Randomized Clinical Trial.
    Jansen TPJ; Konst RE; de Vos A; Paradies V; Teerenstra S; van den Oord SCH; Dimitriu-Leen A; Maas AHEM; Smits PC; Damman P; van Royen N; Elias-Smale SE
    JACC Cardiovasc Imaging; 2022 Aug; 15(8):1473-1484. PubMed ID: 35466050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.